Literature DB >> 28127865

Potocki-Shaffer syndrome in a child without intellectual disability-The role of PHF21A in cognitive function.

Caroline McCool1, Adiaha Spinks-Franklin2,3, Lenora M Noroski3,4, Lorraine Potocki1,3.   

Abstract

Potocki-Shaffer syndrome is a contiguous gene deletion syndrome involving 11p11.2p12 and characterized by multiple exostoses, biparietal foramina, genitourinary anomalies in males, central nervous system abnormalities, intellectual disability, and craniofacial abnormalities. Current literature implicates haploinsufficiency of three genes (ALX4, EXT2, and PHF21A) in causing some of the cardinal features of PSS. We report a patient with multiple exostoses, biparietal foramina, and history of mild developmental delay. Cognitive and behavioral testing supported formal diagnoses of anxiety, verbal dyspraxia, articulation disorder, and coordination disorder, without intellectual disability. His facial features, though distinctive, were not typical of those observed in PSS. As the chromosomal deletion does not encompass PHF21A, this case lends further support that haploinsufficiency of PHF21A contributes to the intellectual disability and craniofacial abnormalities in PSS and that there are other genes in the region which likely contribute to the behavioral phenotype in this syndrome.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  PHF21A; Potocki-Shaffer syndrome; RAG1; contiguous gene deletion syndrome; multiple exostoses

Mesh:

Substances:

Year:  2017        PMID: 28127865     DOI: 10.1002/ajmg.a.37988

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  6 in total

1.  Transcriptome Analysis Revealed Impaired cAMP Responsiveness in PHF21A-Deficient Human Cells.

Authors:  Robert S Porter; Yumie Murata-Nakamura; Hajime Nagasu; Hyung-Goo Kim; Shigeki Iwase
Journal:  Neuroscience       Date:  2017-05-29       Impact factor: 3.590

2.  Novel Pathogenic Variant (c.1171A>T) in PHF21A in a Female with Intellectual Disability and Craniofacial Anomalies.

Authors:  Cheonghwa Lee; Jung Yoon; Borae G Park; Baik-Lin Eun; Jung Ah Kwon
Journal:  Mol Syndromol       Date:  2022-03-09

3.  De novo truncating variants in PHF21A cause intellectual disability and craniofacial anomalies.

Authors:  Kohei Hamanaka; Yuji Sugawara; Takeyoshi Shimoji; Tone Irene Nordtveit; Mitsuhiro Kato; Mitsuko Nakashima; Hirotomo Saitsu; Toshimitsu Suzuki; Kazuhiro Yamakawa; Ingvild Aukrust; Gunnar Houge; Satomi Mitsuhashi; Atsushi Takata; Kazuhiro Iwama; Ahmed Alkanaq; Atsushi Fujita; Eri Imagawa; Takeshi Mizuguchi; Noriko Miyake; Satoko Miyatake; Naomichi Matsumoto
Journal:  Eur J Hum Genet       Date:  2018-11-28       Impact factor: 4.246

4.  Neurodevelopmental disease genes implicated by de novo mutation and copy number variation morbidity.

Authors:  Bradley P Coe; Holly A F Stessman; Arvis Sulovari; Madeleine R Geisheker; Trygve E Bakken; Allison M Lake; Joseph D Dougherty; Ed S Lein; Fereydoun Hormozdiari; Raphael A Bernier; Evan E Eichler
Journal:  Nat Genet       Date:  2018-12-17       Impact factor: 38.330

5.  Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.

Authors:  Hyung-Goo Kim; Jill A Rosenfeld; Daryl A Scott; Gerard Bénédicte; Jonathan D Labonne; Jason Brown; Marianne McGuire; Sonal Mahida; Sakkubai Naidu; Jacqueline Gutierrez; Gaetan Lesca; Vincent des Portes; Ange-Line Bruel; Arthur Sorlin; Fan Xia; Yline Capri; Eric Muller; Dianalee McKnight; Erin Torti; Franz Rüschendorf; Oliver Hummel; Zeyaul Islam; Prasanna R Kolatkar; Lawrence C Layman; Duchwan Ryu; Il-Keun Kong; Suneeta Madan-Khetarpal; Cheol-Hee Kim
Journal:  Mol Autism       Date:  2019-10-22       Impact factor: 7.509

6.  11p11.12p12 duplication in a family with intellectual disability and craniofacial anomalies.

Authors:  Xuejiao Chen; Huihui Xu; Weiwu Shi; Feng Wang; Fenfen Xu; Yang Zhang; Jun Gan; Xiong Tian; Baojun Chen; Meizhen Dai
Journal:  BMC Med Genomics       Date:  2021-04-09       Impact factor: 3.063

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.